• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Coronavirus Disease (COVID-19): A Perspective from Immunosenescence.

作者信息

Genebat Miguel, Tarancón-Díez Laura, de Pablo-Bernal Rebeca, Calderón Alba, Muñoz-Fernández Mª Ángeles, Leal Manuel

机构信息

1Internal Medicine Department, Hospital Fátima, Sevilla, Spain.

2Emergency Department, Virgen del Rocío University Hospital, Sevilla, Spain.

出版信息

Aging Dis. 2021 Feb 1;12(1):3-6. doi: 10.14336/AD.2020.0831. eCollection 2021 Feb.

DOI:10.14336/AD.2020.0831
PMID:33532121
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7801288/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7a7/7801288/df4499f79746/ad-12-1-3-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7a7/7801288/df4499f79746/ad-12-1-3-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b7a7/7801288/df4499f79746/ad-12-1-3-g1.jpg

相似文献

1
Coronavirus Disease (COVID-19): A Perspective from Immunosenescence.冠状病毒病（COVID-19）：免疫衰老视角
Aging Dis. 2021 Feb 1;12(1):3-6. doi: 10.14336/AD.2020.0831. eCollection 2021 Feb.
2
Remodeling of the Immune Response With Aging: Immunosenescence and Its Potential Impact on COVID-19 Immune Response.免疫反应随衰老而重塑：免疫衰老及其对 COVID-19 免疫反应的潜在影响。
Front Immunol. 2020 Aug 7;11:1748. doi: 10.3389/fimmu.2020.01748. eCollection 2020.
3
Immunosenescence and Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Development.免疫衰老与严重急性呼吸综合征冠状病毒2疫苗研发
J Infect Dis. 2020 Nov 13;222(12):2114. doi: 10.1093/infdis/jiaa564.
4
Reversing immunosenescence for prevention of COVID-19.逆转免疫衰老以预防新冠病毒疾病
Aging (Albany NY). 2020 Jun 28;12(12):11161-11162. doi: 10.18632/aging.103636.
5
Immunological Implications of Physical Inactivity among Older Adults during the COVID-19 Pandemic.新冠疫情期间老年人身体不活动的免疫影响。
Gerontology. 2020;66(5):431-438. doi: 10.1159/000509216. Epub 2020 Jun 25.
6
Coronavirus Disease-19 (COVID-19) and Heart Failure: Current Perspective.冠状病毒病-19（COVID-19）与心力衰竭：当前观点
J Assoc Physicians India. 2020 Nov;68(11):66-68.
7
Impact of the coronavirus disease 2019 pandemic on cancer treatment: the patients' perspective.2019 冠状病毒病大流行对癌症治疗的影响：患者视角。
Eur J Cancer. 2020 Sep;136:132-139. doi: 10.1016/j.ejca.2020.06.019. Epub 2020 Jul 4.
8
Coronavirus disease 2019 (COVID-19) and acute cardiovascular disease management: A Chinese perspective on striking the balance.2019冠状病毒病（COVID-19）与急性心血管疾病管理：中国关于实现平衡的观点。
Resuscitation. 2020 Jul;152:36-38. doi: 10.1016/j.resuscitation.2020.05.010. Epub 2020 May 19.
9
Vaccine-induced protection in aging adults and pandemic response.疫苗诱导的老年成年人保护作用与大流行应对措施
Biochem Biophys Res Commun. 2021 Jan 29;538:218-220. doi: 10.1016/j.bbrc.2020.10.090. Epub 2020 Nov 17.
10
Biomarkers of immunosenescence within an evolutionary perspective: the challenge of heterogeneity and the role of antigenic load.进化视角下免疫衰老的生物标志物：异质性挑战与抗原负荷的作用
Exp Gerontol. 1999 Dec;34(8):911-21. doi: 10.1016/s0531-5565(99)00068-6.

引用本文的文献

1
Humoral and cellular response to SARS-CoV-2 mRNA vaccine in paediatric heart transplant recipients.儿童心脏移植受者对SARS-CoV-2 mRNA疫苗的体液和细胞反应。
Heliyon. 2024 Dec 31;11(1):e41584. doi: 10.1016/j.heliyon.2024.e41584. eCollection 2025 Jan 15.
2
The use of alpha 1 thymosin as an immunomodulator of the response against SARS-Cov2.将α1胸腺素用作针对新冠病毒（SARS-CoV2）免疫反应的免疫调节剂。
Immun Ageing. 2023 Jul 5;20(1):32. doi: 10.1186/s12979-023-00351-x.
3
Higher plasma levels of thymosin-α1 are associated with a lower waning of humoral response after COVID-19 vaccination: an eight months follow-up study in a nursing home.

本文引用的文献

1
Impact of renal function on admission in COVID-19 patients: an analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID 19) Registry.肾功能对 COVID-19 患者入院的影响：对国际 HOPE COVID-19（COVID-19 健康结果预测评估）登记的分析。
J Nephrol. 2020 Aug;33(4):737-745. doi: 10.1007/s40620-020-00790-5. Epub 2020 Jun 29.
2
Lymphopenia during the COVID-19 infection: What it shows and what can be learned.新冠病毒感染期间的淋巴细胞减少症：所呈现的情况及可从中了解到的信息。
Immunol Lett. 2020 Sep;225:31-32. doi: 10.1016/j.imlet.2020.06.013. Epub 2020 Jun 20.
3
The possible pathophysiology mechanism of cytokine storm in elderly adults with COVID-19 infection: the contribution of "inflame-aging".
较高的血浆胸腺素α1水平与新冠病毒疫苗接种后体液免疫反应较低的减弱程度相关：一项养老院的八个月随访研究。
Immun Ageing. 2023 Mar 6;20(1):9. doi: 10.1186/s12979-023-00334-y.
4
Aging, inflammaging and immunosenescence as risk factors of severe COVID-19.衰老、炎症衰老和免疫衰老作为重症 COVID-19 的风险因素。
Immun Ageing. 2022 Nov 11;19(1):53. doi: 10.1186/s12979-022-00309-5.
5
The Importance of Behavioral and Native Factors on COVID-19 Infection and Severity: Insights from a Preliminary Cross-Sectional Study.行为因素和固有因素对新型冠状病毒肺炎感染及严重程度的影响：一项初步横断面研究的见解
Healthcare (Basel). 2022 Jul 19;10(7):1341. doi: 10.3390/healthcare10071341.
6
Management of asthma patients during the COVID-19 pandemic: pathophysiological considerations to address the challenges.2019冠状病毒病大流行期间哮喘患者的管理：应对挑战的病理生理学考量
Beni Suef Univ J Basic Appl Sci. 2022;11(1):20. doi: 10.1186/s43088-022-00204-4. Epub 2022 Feb 5.
7
Immunopathology and Immunosenescence, the Immunological Key Words of Severe COVID-19. Is There a Role for Stem Cell Transplantation?免疫病理学与免疫衰老，重症COVID-19的免疫学关键词。干细胞移植能发挥作用吗？
Front Cell Dev Biol. 2021 Sep 14;9:725606. doi: 10.3389/fcell.2021.725606. eCollection 2021.
8
Fat-Soluble Vitamins and the Current Global Pandemic of COVID-19: Evidence-Based Efficacy from Literature Review.脂溶性维生素与当前全球新冠疫情：基于文献综述的循证疗效
J Inflamm Res. 2021 May 21;14:2091-2110. doi: 10.2147/JIR.S307333. eCollection 2021.
COVID-19 感染老年患者细胞因子风暴的可能病理生理学机制：“炎症性衰老”的作用。
Inflamm Res. 2020 Sep;69(9):825-839. doi: 10.1007/s00011-020-01372-8. Epub 2020 Jun 11.
4
COVID-19 in India: Are Biological and Environmental Factors Helping to Stem the Incidence and Severity?印度的新冠疫情：生物和环境因素是否有助于遏制发病率和严重程度？
Aging Dis. 2020 May 9;11(3):480-488. doi: 10.14336/AD.2020.0402. eCollection 2020 May.
5
Thymosin Alpha 1 Reduces the Mortality of Severe Coronavirus Disease 2019 by Restoration of Lymphocytopenia and Reversion of Exhausted T Cells.胸腺素 α1 通过恢复淋巴细胞减少症和逆转耗竭 T 细胞来降低严重 COVID-19 的死亡率。
Clin Infect Dis. 2020 Nov 19;71(16):2150-2157. doi: 10.1093/cid/ciaa630.
6
Role of thymopoiesis and inflamm-aging in COVID-19 phenotype.胸腺生成和炎症衰老在新冠病毒疾病表型中的作用。
Pediatr Neonatol. 2020 Jun;61(3):364-365. doi: 10.1016/j.pedneo.2020.04.001. Epub 2020 Apr 15.
7
Anti-IL6R role in treatment of COVID-19-related ARDS.抗白细胞介素6受体在治疗新型冠状病毒肺炎相关急性呼吸窘迫综合征中的作用
J Transl Med. 2020 Apr 14;18(1):165. doi: 10.1186/s12967-020-02333-9.
8
Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients.新型冠状病毒肺炎患者支气管肺泡灌洗液和外周血单个核细胞的转录组学特征。
Emerg Microbes Infect. 2020 Dec;9(1):761-770. doi: 10.1080/22221751.2020.1747363.
9
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素：一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
10
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China.中国武汉 2019 年冠状病毒病（COVID-19）患者免疫反应失调。
Clin Infect Dis. 2020 Jul 28;71(15):762-768. doi: 10.1093/cid/ciaa248.